Genetic testing company 23andMe is preparing for a renewed auction of its assets after a federal judge agreed to reopen the ...

The move marks a turning point in 23andMe’s tumultuous decline. Founded in 2006 by Wojcicki, the company initially gained traction with its saliva-based ancestry kits and went public in 2021. By the ...

The sale of genetic testing company 23andMe—which includes genetic data from around 16 million customers—took a new turn at a ...

Once a Silicon Valley pioneer in consumer genetic testing, 23andMe is now at the center of a high-stakes legal and financial ...

The fate of genetic data belonging to millions of 23andMe customers is again up in the air, as the bankrupt company seeks a ...

Me will hold a second auction for its DNA data with an opening bid of $305 million from former CEO Anne Wojcicki. Here's all ...

Bankrupt genetic testing company 23andMe is looking to sell its assets — most notably its customers' DNA data — for more than ...

Added to that, 23andMe suffered a massive data breach in 2023 that resulted in information from about 7 million people being ...

A buyer had actually already been found for 23andme, but a competitor is not giving up: The ex-boss of the company may have ...

Me wants to reopen bidding on its assets after former CEO Anne Wojcicki put together a $305 million offer, topping Regeneron.

Me (OTC:MEHCQ) faces a second auction after a $305M bid challenges Regeneron's (REGN) initial bid for its assets. Read more ...

The new offer is nearly $50m more than the last bid from Regeneron Pharmaceuticals, which had been declared the winner of the ...